Add BrightSurf on Google Email

Telemedicine had an impact on carbon emissions equivalent to reducing up to 130,000 car trips each month in 2023

New UCLA-led research finds that telemedicine use in 2023 reduced monthly CO2 emissions by the equivalent of 61,000 to 130,000 gas powered vehicles. This modest but noticeable impact on the environment could have policy implications for US healthcare delivery.

SourceUniversity of California - Los Angeles Health Sciences·JournalThe American Journal of Managed Care·TypeData/statistical analysis·DateApr 22, 2025

Hospitalized patients who receive alcohol use disorder treatment can substantially reduce heavy drinking

A new study found that both oral and injectable forms of naltrexone are effective in reducing heavy drinking among hospitalized patients. The medication was administered before discharge, resulting in a significant decrease in heavy drinking within the last 30 days of the three-month follow-up period.

SourceBoston University School of Public Health·JournalJAMA Internal Medicine·TypeRandomized controlled/clinical trial·DateApr 21, 2025

Pediatric investigation publishes China’s first clinical guidelines for juvenile-onset recurrent respiratory papillomatosis

Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare disease causing chronic hoarseness and breathing difficulties in children. New clinical guidelines provide actionable recommendations for early recognition, diagnosis, and treatment to improve long-term outcomes.

SourcePediatric Investigation·JournalPediatric Investigation·TypeSystematic review·DateApr 21, 2025

New analytics-driven framework aims to improve care of chronic disease

Researchers developed an analytics-driven framework to improve chronic disease care by tailoring patient encounters based on socioeconomic and demographic factors. The study found disparities in care access among underserved populations, highlighting the need for risk-sensitive decision-making processes.

SourceUniversity of Illinois at Urbana-Champaign, News Bureau·JournalJournal of Operations Management·TypeData/statistical analysis·DateApr 21, 2025

Medicaid expansion improves timely lung cancer treatment and access to high-volume hospitals

A new study published in The Annals of Thoracic Surgery found that Medicaid expansion significantly improved access to timely treatment for patients with early-stage non-small cell lung cancer. High-volume hospitals associated with decreased postoperative complications and in-hospital mortality rates compared to low-volume hospitals.

SourceThe Society of Thoracic Surgeons·JournalThe Annals of Thoracic Surgery·TypeData/statistical analysis·DateApr 15, 2025

Do disasters delay early cancer diagnoses?

A recent analysis found that rates of colorectal cancer diagnoses dropped during Hurricanes Irma and Maria and the COVID-19 pandemic in Puerto Rico, but late-stage diagnoses eventually exceeded expectations. Limited access to cancer screening services due to these disasters likely hindered timely CRC diagnoses.

SourceWiley·JournalCancer·DateApr 14, 2025

AGS honors Dr. Christine K. Wanich Bradway with Dennis W. Jahnigen Memorial Award at #AGS25 for proven excellence in geriatrics education

Dr. Christine K. Wanich Bradway is recognized for her dedication to improving care for older adults through education and research, particularly in urinary incontinence and severe obesity. She has shaped the field of gerontological nursing and will receive the prestigious Dennis W. Jahnigen Memorial Award at the #AGS25 Annual Scientifi...

A new smartphone-sized device can test for tuberculosis. Here’s why that matters for children

Tulane University scientists developed a handheld device to deliver rapid and accurate tuberculosis diagnoses in under an hour. The device, called the lab-in-tube assay (LIT), can detect Mycobacterium tuberculosis DNA in saliva, blood, and sputum samples, offering a cost-effective tool for improving TB diagnoses in resource-limited areas.

SourceTulane University·JournalScience Translational Medicine·DateApr 9, 2025

Perspectives on obesity management and the use of anti-obesity medicine

A new study found that both employed people with obesity and employer representatives acknowledge the impact of obesity on future health problems and perceive lifestyle change alongside anti-obesity medications as the most effective approach for maintaining weight-loss reduction. Cost of medication coverage remains a significant barrie...

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalPopulation Health Management·TypeSurvey·DateApr 9, 2025

Breakthrough research revolutionizing pulmonary hypertension treatment

A recent study published in the International Journal of Cardiology analyzed data from multiple clinical trials to assess the therapeutic impact of pulmonary artery denervation (PADN) on pulmonary hypertension patients. PADN showed significant reductions in mean right atrial pressure, mean pulmonary artery pressure, and pulmonary vascu...

SourceOchsner Health System·JournalInternational Journal of Cardiology·DateApr 8, 2025

UT Health San Antonio neurologists among first to treat patients with deep brain stimulation that adapts to patients’ symptoms

Researchers at UT Health San Antonio are among the first to use adaptive deep brain stimulation technology that adjusts treatment based on a patient's symptoms. This innovative approach offers improved therapy and symptom optimization for patients with Parkinson's disease, dystonia, epilepsy, and essential tremor conditions.

March/April Annals of Family Medicine Tip Sheet

A family-based approach to lifestyle interventions significantly improves weight management and cardiovascular health among individuals with a family history of premature coronary heart disease. The study found that participants who received structured lifestyle counseling experienced notable reductions in weight, BMI, and waist circum...

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateMar 24, 2025

Results of the INHALE-3 extension study: inhaled technosphere insulin plus insulin degludec in T1D

The INHALE-3 extension study found that a regimen of inhaled technosphere insulin and insulin degludec reduced post-meal hyperglycemia in adults with type 1 diabetes. The treatment showed significant improvements in mean time in range, with 43% of participants expressing interest in continuing the regimen.

SourceMary Ann Liebert, Inc./Genetic Engineering News·JournalDiabetes Technology & Therapeutics·TypeRandomized controlled/clinical trial·DateMar 22, 2025

Older immigrants and immigrants with dementia face similar barriers to accessing social and medical services

A recent study by the University of Eastern Finland reveals that linguistic barriers, lack of digital skills, and cultural differences hinder older immigrants' access to social and medical services. Family members and communities play a crucial role in facilitating access, but NGOs require state support to overcome resource limitations.

SourceUniversity of Eastern Finland·JournalJournal of Cross-Cultural Gerontology·DateMar 19, 2025